These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 12043223)

  • 21. Concurrent chemoradiotherapy followed by adjuvant chemotherapy in uterine cervical cancer patients with high-risk factors.
    Kim YB; Cho JH; Keum KC; Lee CG; Seong J; Suh CO; Kim GE
    Gynecol Oncol; 2007 Jan; 104(1):58-63. PubMed ID: 16919718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor diameter and volume assessed by magnetic resonance imaging in the prediction of outcome for invasive cervical cancer.
    Wagenaar HC; Trimbos JB; Postema S; Anastasopoulou A; van der Geest RJ; Reiber JH; Kenter GG; Peters AA; Pattynama PM
    Gynecol Oncol; 2001 Sep; 82(3):474-82. PubMed ID: 11520143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Development of a cancer of the large bowel following radiotherapy for cancer of the uterine cervix].
    Tomoda H; Furusawa M; Hayashi I
    Gan No Rinsho; 1989 Dec; 35(15):1749-52. PubMed ID: 2607608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns of radiotherapy practice for patients with cervical cancer (1999-2001): patterns of care study in Japan.
    Toita T; Kodaira T; Shinoda A; Uno T; Akino Y; Mitsumori M; Teshima T
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):788-94. PubMed ID: 18191331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quality assurance in the prospective multi-institutional trial on definitive radiotherapy using high-dose-rate intracavitary brachytherapy for uterine cervical cancer: the individual case review.
    Toita T; Oguchi M; Ohno T; Kato S; Niibe Y; Kodaira T; Kazumoto T; Kataoka M; Shikama N; Kenjo M; Teshima T; Kagami Y
    Jpn J Clin Oncol; 2009 Dec; 39(12):813-9. PubMed ID: 19815538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential for use of amifostine in cervical cancer.
    Small W
    Semin Oncol; 2002 Dec; 29(6 Suppl 19):34-7. PubMed ID: 12577241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Studies on serum protein fractions of patients with uterine cervical cancer undergoing radiotherapy: relationship between changes in serum protein fractions and prognosis].
    Onizuka K; Migita S; Yamada H; Uwada O; Umemura Y; Kuroki M; Tateyama H
    Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Sep; 54(10):1007-17. PubMed ID: 7971179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Meta-analyses of the effects of radiotherapy in breast cancer: the ultimate evidence?].
    Fourquet A; Kirova Y; Bollet MA; Tournat H; Dendale R; Campana F
    Cancer Radiother; 2008 Nov; 12(6-7):554-8. PubMed ID: 18838328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thymidine phosphorylase expression is preserved after radiotherapy in patients with cervical squamous cell carcinoma.
    Oguri H; Maeda N; Yamamoto Y; Kusume T; Fukaya T
    Cancer Chemother Pharmacol; 2004 Feb; 53(2):151-4. PubMed ID: 14614573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current approaches of neoadjuvant chemotherapy in cervical cancer.
    Aoki Y; Tanaka K
    Expert Rev Anticancer Ther; 2002 Feb; 2(1):73-82. PubMed ID: 12113071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Tolerance dose of the small intestines and colon in patients with carcinoma of the uterine cervix].
    Teshima T; Chatani M; Masaki N; Inoue T
    Gan No Rinsho; 1990 Oct; 36(13):2313-8. PubMed ID: 2250351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An assessment of interfractional uterine and cervical motion: implications for radiotherapy target volume definition in gynaecological cancer.
    Taylor A; Powell ME
    Radiother Oncol; 2008 Aug; 88(2):250-7. PubMed ID: 18538873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. From data to evidence: evaluative methods in evidence-based medicine.
    Landry MD; Sibbald WJ
    Respir Care; 2001 Nov; 46(11):1226-35. PubMed ID: 11679144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Lymphadenectomy for uterine cancer].
    Gouy S; Uzan C; Zafrani Y; Lhommé C; Pautier P; Duvillard P; Haie-Meder C; Morice P
    J Chir (Paris); 2008 Dec; 145 Spec no. 4():12S51-12S55. PubMed ID: 19194359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemotherapy in the primary treatment of cervical carcinoma.
    Serkies K; Jassem J
    Crit Rev Oncol Hematol; 2005 Jun; 54(3):197-208. PubMed ID: 15890269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dosimetric parameters that predict late rectal complications after curative radiotherapy in patients with uterine cervical carcinoma.
    Hyun Kim T; Choi J; Park SY; Lee SH; Lee KC; Yang DS; Shin KH; Cho KH; Lim HS; Kim JY
    Cancer; 2005 Sep; 104(6):1304-11. PubMed ID: 16078262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant chemotherapy or radiotherapy in cervical cancer.
    Gao X
    Gynecol Oncol; 2000 May; 77(2):340-1. PubMed ID: 10785495
    [No Abstract]   [Full Text] [Related]  

  • 38. An ontological approach to evidence-based medicine and meta-analysis.
    Pisanelli DM; Zaccagnini D; Capurso L; Koch M
    Stud Health Technol Inform; 2003; 95():543-8. PubMed ID: 14664043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How valid are current cervical cancer prognostic factors that are used to recommend adjunctive radiation therapy after radical surgery?
    Creasman WT; Kohler M; Korte JE
    Am J Obstet Gynecol; 2009 Sep; 201(3):260.e1-3. PubMed ID: 19539891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Management of cervical cancer].
    Hashimoto K
    Nihon Sanka Fujinka Gakkai Zasshi; 1968 Apr; 20(4):445-9. PubMed ID: 5748490
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.